Literature DB >> 23569271

Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.

Frida Danielsson1, Marie Skogs, Mikael Huss, Elton Rexhepaj, Gillian O'Hurley, Daniel Klevebring, Fredrik Pontén, Annica K B Gad, Mathias Uhlén, Emma Lundberg.   

Abstract

The transformation of normal cells to malignant, metastatic tumor cells is a multistep process caused by the sequential acquirement of genetic changes. To identify these changes, we compared the transcriptomes and levels and distribution of proteins in a four-stage cell model of isogenically matched normal, immortalized, transformed, and metastatic human cells, using deep transcriptome sequencing and immunofluorescence microscopy. The data show that ∼6% (n = 1,357) of the human protein-coding genes are differentially expressed across the stages in the model. Interestingly, the majority of these genes are down-regulated, linking malignant transformation to dedifferentiation. The up-regulated genes are mainly components that control cellular proliferation, whereas the down-regulated genes consist of proteins exposed on or secreted from the cell surface. As many of the identified gene products control basic cellular functions that are defective in cancers, the data provide candidates for follow-up studies to investigate their functional roles in tumor formation. When we further compared the expression levels of four of the identified proteins in clinical cancer cohorts, similar differences were observed between benign and cancer cells, as in the cell model. This shows that this comprehensive demonstration of the molecular changes underlying malignant transformation is a relevant model to study the process of tumor formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23569271      PMCID: PMC3637701          DOI: 10.1073/pnas.1216436110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  The septin-binding protein anillin is overexpressed in diverse human tumors.

Authors:  Peter A Hall; Christopher B Todd; Paula L Hyland; Simon S McDade; Heike Grabsch; Mit Dattani; Kenneth J Hillan; S E Hilary Russell
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

Review 3.  SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.

Authors:  Deepika Ahuja; M Teresa Sáenz-Robles; James M Pipas
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 4.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 5.  Cellular oncogenes and multistep carcinogenesis.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

6.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

7.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

8.  Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family.

Authors:  H Toyoda; T Komurasaki; D Uchida; S Morimoto
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

9.  The role of chromosomal instability in tumor initiation.

Authors:  Martin A Nowak; Natalia L Komarova; Anirvan Sengupta; Prasad V Jallepalli; Ie-Ming Shih; Bert Vogelstein; Christoph Lengauer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-21       Impact factor: 11.205

10.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

View more
  19 in total

Review 1.  Anillin is an emerging regulator of tumorigenesis, acting as a cortical cytoskeletal scaffold and a nuclear modulator of cancer cell differentiation.

Authors:  Nayden G Naydenov; Jennifer E Koblinski; Andrei I Ivanov
Journal:  Cell Mol Life Sci       Date:  2020-09-03       Impact factor: 9.261

2.  Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma.

Authors:  Francesco Gatto; Intawat Nookaew; Jens Nielsen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

3.  Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness.

Authors:  Li-Sophie Z Rathje; Niklas Nordgren; Torbjörn Pettersson; Daniel Rönnlund; Jerker Widengren; Pontus Aspenström; Annica K B Gad
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 4.  Increasing the Content of High-Content Screening: An Overview.

Authors:  Shantanu Singh; Anne E Carpenter; Auguste Genovesio
Journal:  J Biomol Screen       Date:  2014-04-07

5.  The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis.

Authors:  Fraser Soares; Ivan Tattoli; Muhammed A Rahman; Susan J Robertson; Antoaneta Belcheva; Daniel Liu; Catherine Streutker; Shawn Winer; Daniel A Winer; Alberto Martin; Dana J Philpott; Damien Arnoult; Stephen E Girardin
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

6.  GeneGini: Assessment via the Gini Coefficient of Reference "Housekeeping" Genes and Diverse Human Transporter Expression Profiles.

Authors:  Steve O'Hagan; Marina Wright Muelas; Philip J Day; Emma Lundberg; Douglas B Kell
Journal:  Cell Syst       Date:  2018-02-07       Impact factor: 10.304

7.  Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.

Authors:  Gillian O'Hurley; Christer Busch; Linn Fagerberg; Björn M Hallström; Charlotte Stadler; Anna Tolf; Emma Lundberg; Jochen M Schwenk; Karin Jirström; Anders Bjartell; William M Gallagher; Mathias Uhlén; Fredrik Pontén
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

8.  Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.

Authors:  Quan-Yi Zhao; Pin-Ji Lei; Xiaoran Zhang; Jun-Yi Zheng; Hui-Yi Wang; Jiao Zhao; Yi-Ming Li; Mei Ye; Lianyun Li; Gang Wei; Min Wu
Journal:  Clin Epigenetics       Date:  2016-03-31       Impact factor: 6.551

9.  Karyotype alteration generates the neoplastic phenotypes of SV40-infected human and rodent cells.

Authors:  Mathew Bloomfield; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2015-10-22       Impact factor: 2.009

10.  Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.

Authors:  Sudheer Kumar Gara; Yonghong Wang; Dhaval Patel; Yi Liu-Chittenden; Meenu Jain; Myriem Boufraqech; Lisa Zhang; Paul S Meltzer; Electron Kebebew
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.